E-mail this Article (login required)
E-mail the Author (login required)
Post a Comment (login required)
VIEW COMPLETE HTML
VIEW COMPLETE PDF
When Hypereosinophilia Leads to Stroke
Emilie Chalayer, Aude Pelissier, Bernard Tardy
http://dx.doi.org/10.12890/2017_000614
European Journal of Case Reports in Internal Medicine - © EFIM

ABSTRACT

AFIP1L1-PDGFRA fusion can only be confirmed through molecular and cytogenetic investigations causing a delay in the diagnosis. However, patients with this mutation need urgent treatment because they present hypereosinophilia which may be associated with short-term tissue damage. Thromboembolism is a known cause of death in hypereosinophilic syndrome. A case of Loeffler endocarditis due to FIP1L1-PDGFRA-associated chronic eosinophilic leukemia presenting hemiparesis with fever, which also mislead the initial diagnosis, is reported.

KEYWORDS

Hypereosinophilia, stroke, cytomegalovirus, Loeffer endocarditis

References
  1. Gotlib J. World Health Organization-defined eosinophilic disorders: 2015 update on diagnosis, risk stratification, and management. Am J Hematol/em> 2015;90:1077–89.
  2. Hyams C, Mabayoje DA, Copping R, Maranao D, Patel M, Labbett W, et al. Serological cross reactivity to CMV and EBV causes problems in the diagnosis of acute hepatitis E virus infection. J Med Virol 2014;86:478–83.
  3. Lioger B, Debiais S, Lauvin MA, Bonnaud I, Maillot F, Ferreira-Maldent N. Anticardiolipin antibodies-associated stroke in primary CMV infection. Eur J Neurol 2013;20:e105–6.


© EFIM Copyright 2016